MedPath

Expressive Writing and Adjustment to Metastatic Breast Cancer

Completed
Conditions
Metastatic Breast Cancer
Interventions
Behavioral: Writing Intervention
Registration Number
NCT00624156
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

We are doing this study to see if writing about life experiences helps women adjust to breast cancer that has spread. We will compare two groups. One group will write about their breast cancer experience. The other will write about their daily activities. What we learn from this study may help us to find new ways to help women cope with breast cancer that has spread.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
98
Inclusion Criteria
  • Women with Stage IV breast cancer
  • Receiving cancer care at Memorial Sloan-Kettering Cancer Center
  • At least 18 years of age
  • Can speak, read, and write in English
  • In the judgment of consenting professionals able to provide informed consent
  • Score of 4 or higher on the distress thermometer (established cutoff score for probable distress; see Jacobsen et al., 2005)
Read More
Exclusion Criteria
  • Significant psychiatric or cognitive impairment (dementia/delirium, retardation, psychosis) that in the judgment of the investigators will preclude providing informed consent and participating in the intervention
  • Currently engaging in expressive writing (e.g., journal writing that involves expressing one's feelings) on a daily basis
  • Currently participating in intervention trials with similar endpoints • Male
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1Writing Interventionemotional disclosure writing intervention
2Writing Interventioncontrol writing
Primary Outcome Measures
NameTimeMethod
Determine the potential utility of expressive writing for enhancing existential well-being (i.e., increasing a sense of meaning and peace and reducing demoralization) among women with metastatic breast cancer.conclusion of the study
Secondary Outcome Measures
NameTimeMethod
Determine the potential utility of expressive writing for reducing distress (i.e., depressive symptoms, anxiety, cancer-specific and general distress) among women with metastatic breast cancer.conclusion of the study

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath